Brief: Surface Oncology Announces Q3 Loss Per Share $0.39
10/11/2020 11:30
Nov 10 (Reuters) - Surface Oncology Inc SURF.O :
* Q3 LOSS PER SHARE $0.39
* CONTINUES TO PROJECT THAT CURRENT CASH AND CASH
EQUIVALENTS ARE
SUFFICIENT TO FUND THE COMPANY INTO 2022.
* Q3 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA
Source: [ID: https://bit.ly/3eVXqr7]
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing